Published on in Vol 11, No 2 (2019): Apr-Jun
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/11167, first published
.
Journals
- McIntyre R, Lipsitz O, Rodrigues N, Subramaniapillai M, Nasri F, Lee Y, Fehnert B, King J, Chrones L, Kratiuk K, Uddin S, Rosenblat J, Mansur R, McCue M. An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study. JMIR Mental Health 2022;9(10):e33871 View
- Wakode S, Hulke S, Sutar R, Thakare A. Comparative change in P300 indices following antidepressant treatment in patients with major depressive disorder. Industrial Psychiatry Journal 2022;31(2):243 View
- Raveendran S, Singh D, Burke M, McAuliffe-Fogarty A, Parikh S, McIntyre R, Roy A, Martin M, Chrones L, Opler M, Blair C, McCue M. Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey. BMC Psychiatry 2023;23(1) View
- Rosenberg R, Thorpy M, Doghramji K, Morse A. Brain fog in central disorders of hypersomnolence: a review. Journal of Clinical Sleep Medicine 2024;20(4):643 View
- Ishihara Y, Sugawara N, Kawamata Y, Yasui‐Furukori N. Initial psychotropic prescriptions and symptom associations in first‐visit patients with major depressive disorder: A single‐center cross‐sectional study. Neuropsychopharmacology Reports 2024 View